EPLink Begins Delivering Clinical Trial Participant Recruitment Ads on 'Rakuten Healthcare' and Other Platforms

EPLink Co., Ltd. (Headquarters: Shinjuku-ku, Tokyo; President and CEO: Hirotaka Nakashima; hereinafter "EPLink") has entered into a service outsourcing agreement with Rakuten Group, Inc. (Headquarters: Setagaya-ku, Tokyo; Chairman and CEO: Hiroshi Mikitani; hereinafter "Rakuten") to begin full-scale distribution of advertisements recruiting participants for clinical trials (human subject research) on "Rakuten Healthcare," a smartphone app operated by Rakuten that enables users to manage their health while earning points, and other related platforms.

Since 2025, EPLink has conducted trial ad campaigns for 14 clinical trials, verifying operational effectiveness and confirming the value of this initiative, which has led to the current full rollout.

While eligible participant enrollment is essential for the smooth execution of clinical trials, the general public currently has limited access to information about such trials.

Given this context, EPLink—leveraging Rakuten's extensive user base and its own expertise in clinical trial support—will deliver targeted advertisements to expand access and participation opportunities.

Going forward, EPLink will gradually broaden the scope of eligible clinical trials and the range of information provided, while actively disseminating information through various channels to reach more people with awareness of clinical trial participation as a viable option.

<Inquiries regarding this announcement>

Recruitment Promotion Section, Project Promotion Department, EPLink Co., Ltd.

E-mail: [email protected]